Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicholas Huby"'
Autor:
Huifeng Niu, David Heimbrook, Aruna Railkar, Jia Kui Li, Harpreet K. Sandhu, Petra Goelzer, Mei Liu, Nader Fotouhi, Nicholas Huby, John Moliterni, Christine Rizzo, Huisheng Wang, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Sherif Daouti
Supplementary Figures 1-2 from Preclinical In vivo Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27a81b81845d3a1a9eea544506caaef
https://doi.org/10.1158/1535-7163.22484477.v1
https://doi.org/10.1158/1535-7163.22484477.v1
Autor:
Huifeng Niu, David Heimbrook, Aruna Railkar, Jia Kui Li, Harpreet K. Sandhu, Petra Goelzer, Mei Liu, Nader Fotouhi, Nicholas Huby, John Moliterni, Christine Rizzo, Huisheng Wang, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Sherif Daouti
Targeting the Ras/Raf/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway represents a promising anticancer strategy. Recently, we have reported a novel class of potent and selective non–ATP-competitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f11847fc95e122e6d967121d5c49bd
https://doi.org/10.1158/1535-7163.c.6531425.v1
https://doi.org/10.1158/1535-7163.c.6531425.v1
Autor:
Huifeng Niu, David Heimbrook, Nader Fotouhi, Yang He, Frank J. Podlaski, Qing Xiang, Yang Wen, Nicholas Huby, Norman Kong, Anthony Specian, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Wen-hui Li, Huisheng Wang, Sherif Daouti
Supplementary Table 2 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cba6738a2cc5ae24baa77c3cff35447d
https://doi.org/10.1158/0008-5472.22380918
https://doi.org/10.1158/0008-5472.22380918
Autor:
Huifeng Niu, David Heimbrook, Nader Fotouhi, Yang He, Frank J. Podlaski, Qing Xiang, Yang Wen, Nicholas Huby, Norman Kong, Anthony Specian, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Wen-hui Li, Huisheng Wang, Sherif Daouti
Supplementary Table 1 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76d6a07f034b88e1c9dc966ccd7aaa31
https://doi.org/10.1158/0008-5472.22380921
https://doi.org/10.1158/0008-5472.22380921
Autor:
Huifeng Niu, David Heimbrook, Nader Fotouhi, Yang He, Frank J. Podlaski, Qing Xiang, Yang Wen, Nicholas Huby, Norman Kong, Anthony Specian, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Wen-hui Li, Huisheng Wang, Sherif Daouti
The mitogen-activated protein kinase (MAPK) signal transduction pathway plays a central role in regulating tumor cell growth, survival, differentiation, and angiogenesis. The key components of the Ras/Raf/MEK/ERK signal module are frequently altered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3fe75ffc9b636be5d87be466a1b0cc
https://doi.org/10.1158/0008-5472.c.6499710.v1
https://doi.org/10.1158/0008-5472.c.6499710.v1
Autor:
Huifeng Niu, David Heimbrook, Nader Fotouhi, Yang He, Frank J. Podlaski, Qing Xiang, Yang Wen, Nicholas Huby, Norman Kong, Anthony Specian, Kathryn Packman, Kenneth Kolinsky, Brian Higgins, Wen-hui Li, Huisheng Wang, Sherif Daouti
Supplementary Table Legends 1-2 from Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2c52c9ad9b007bd2ae3fc112e52151
https://doi.org/10.1158/0008-5472.22380915.v1
https://doi.org/10.1158/0008-5472.22380915.v1